About US
Contact us
-
J&J, Legend's new CAR-T data; Junshi's antiviral tops Pfizer's Paxlovid; Vir, WuXi end COVID pactJohnson & Johnson and Legend Biotech further padded the case for their BCMA CAR-T therapy Carvyktiin multiple myeloma. Junshi Biosciences said a China phase 3 trial has found its oral COVID antiv2022/6/30
-
Samsung Biologics ties up with Novartis in $81M contract manufacturing dealSamsung Biologics has signed an initial $81 million contract manufacturing and development deal with Novartis, marking the first time the two companies have worked together. Samsung Biologicsre2022/6/30
-
Sanofi union members set strike date in Korea as wage negotiations stall: reportFed up with a low salary increase, unionized Sanofi workers in South Korea have threatened to go on strike. The workers will strike next month after failing to reach an agreement on a new wage2022/6/28
-
Enhertu's standing ovation; Tessa's $126M CAR-T financing; Samsung's manufacturing dealAstraZeneca and Daiichi Sankyo's Enhertulooked on track to open a new breast cancer category: HER2-low. Singapore's Tessa Therapeutics grabbed $126 million in a series A to advance its CAR-T programs2022/6/28
-
Game on, Pfizer: Merck's Vaxneuvance boosts pneumococcal vaccine fight with coveted pediatric nodThis spring, when the FDA pushed its target date for pediatric approval of Merck’s pneumococcal vaccine Vaxneuvance back by 90 days, it was a blow to the company’s hope to get its next-generation sho2022/6/23
-
Enanta sues Pfizer for infringement on Paxlovid, citing a patent it was granted a week agoEarlier this year, Enanta Pharmaceuticalssaidit was entering the clinic with a COVID-19 treatment that might eventually challenge Pfizer’s antiviral Paxlovid. Five months later, the biotech has2022/6/23
-
Florida man arrested in scheme to sell $230M in adulterated HIV meds to unsuspecting patientsAs authorities continue to probeirregularities in the HIV drug supply chain, aFlorida man has been arrested for his alleged role in a nationwide scheme to defraud the FDA and illegally distribute mor2022/6/21
-
Novartis' recent Gilenya patent win slips away after appeals court reverses its own prior verdictAfter handing Novartis a win in January, a U.S. appeals court has changed course in a Gilenya patent infringement lawsuit. On Tuesday, the judges revived a Chinese drugmaker’s bid to challenge the bl2022/6/21
-
Chasing Sage, PureTech's oral depression drug clears early bioavailability testPureTech Health has cleared an early hurdle in its pursuit of Sage Therapeutics,linkingits oral prodrug of allopregnanolone to a nine-fold increase in the blood levels achieved by the unmodified mole2022/6/16
-
Amylyx's ALS drug prospect could raise cost concerns, ICER contendsJust one day after Amylyx Pharmaceuticals’ new amyotrophic lateral sclerosis (ALS) med Albrioza passed muster with Canadian regulators, U.S. watchdog ICER has taken aim at the drug’s cost-effectivene2022/6/16